Patients diagnosed with oral and pharyngeal (OP) cancer have a substantial excess risk of second OP cancer, but risk quantification is still uncertain and scanty information is available on the absolute excess risk of second OP cancer. We considered the risk of second OP primary cancer in a population-based series of 3,092 first primary OP cancers registered between 1974 and 2003 in the Swiss Cantons of Vaud and Neuchatel (total population of about 786,000 inhabitants). A total of 233 second OP cancers were registered, versus 7.4 expected, corresponding to a SIR of 31.7 (95% confidence interval (CI) 27.7-36.0). The SIR was 68.5 in the first year after diagnosis of the first primary, and declined thereafter, leveling around 20. The SIR was 3...
Objective: Head and neck cancer (HNC) is the sixth leading cancer worldwide with approximately 600,0...
BACKGROUND. There are only limited population-based data available regarding the risk of developing ...
Second primary tumours in patients treated for oral cancer occur at a rate of 3% to 7% per year. The...
Patients diagnosed with oral and pharyngeal (OP) cancer have a substantial excess risk of second OP ...
The authors considered the incidence of second neoplasms among 1,672 oesophageal cancers diagnosed b...
Scanty data are available on the incidence (i.e., the absolute risk) of second cancers of the head a...
Scanty data are available on the incidence (i.e., the absolute risk) of second cancers of the head a...
Scanty data are available on the incidence (i.e., the absolute risk) of second cancers of the head a...
Objective: Head and neck cancer survivors have increased risk of developing second primary tumors co...
The aim of this study was to define the incidence of second primary tumours (SPTs) after treatment o...
Background: The objective of this study is to assess the risk of second primary cancers following a ...
BACKGROUND: Second primary tumors (SPTs) are a common cause of reduced life expectancy in patients t...
Abstract Background: The incidence and survival of oral squamous cell carcinoma (OSCC) patients hav...
BACKGROUND: Second primary tumors (SPTs) are a common cause of reduced life expectancy in patients t...
This is a review on second primary tumors in patients with head and neck cancer. These patients have...
Objective: Head and neck cancer (HNC) is the sixth leading cancer worldwide with approximately 600,0...
BACKGROUND. There are only limited population-based data available regarding the risk of developing ...
Second primary tumours in patients treated for oral cancer occur at a rate of 3% to 7% per year. The...
Patients diagnosed with oral and pharyngeal (OP) cancer have a substantial excess risk of second OP ...
The authors considered the incidence of second neoplasms among 1,672 oesophageal cancers diagnosed b...
Scanty data are available on the incidence (i.e., the absolute risk) of second cancers of the head a...
Scanty data are available on the incidence (i.e., the absolute risk) of second cancers of the head a...
Scanty data are available on the incidence (i.e., the absolute risk) of second cancers of the head a...
Objective: Head and neck cancer survivors have increased risk of developing second primary tumors co...
The aim of this study was to define the incidence of second primary tumours (SPTs) after treatment o...
Background: The objective of this study is to assess the risk of second primary cancers following a ...
BACKGROUND: Second primary tumors (SPTs) are a common cause of reduced life expectancy in patients t...
Abstract Background: The incidence and survival of oral squamous cell carcinoma (OSCC) patients hav...
BACKGROUND: Second primary tumors (SPTs) are a common cause of reduced life expectancy in patients t...
This is a review on second primary tumors in patients with head and neck cancer. These patients have...
Objective: Head and neck cancer (HNC) is the sixth leading cancer worldwide with approximately 600,0...
BACKGROUND. There are only limited population-based data available regarding the risk of developing ...
Second primary tumours in patients treated for oral cancer occur at a rate of 3% to 7% per year. The...